| 25 May 2026 |
17a-Methyl-1-Testosterone |
5.7 |
100mg |
123.9mg |
+23.9% |
99.55% |
Lab B |
| 25 May 2026 |
Retatrutide 30mg Pen Kit |
4.0 |
10mg |
11.3mg |
+12.6% |
96.88% |
Lab B |
| 24 May 2026 |
5-amino-1MQ Oral |
5.6 |
20mg |
23.2mg |
+16.2% |
98.52% |
Lab D |
| 24 May 2026 |
AA Water |
4.3 |
30mg |
28.9mg |
-3.8% |
98.89% |
Lab D |
| 24 May 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
6.8 |
20mg |
18.2mg |
-9.2% |
99.57% |
Lab F |
| 24 May 2026 |
Dapoxetine |
4.6 |
10mg |
8.9mg |
-11.3% |
99.24% |
Lab B |
| 24 May 2026 |
Anavar (Oxandrolone) |
7.4 |
25mg |
28.7mg |
+14.7% |
95.95% |
Lab E |
| 24 May 2026 |
KissPeptin-10 |
6.0 |
30mg |
30.2mg |
+0.8% |
98.07% |
Lab D |
| 24 May 2026 |
Trenbolone Acetate Raw |
7.8 |
5g |
4.7g |
-6.3% |
95.47% |
Lab E |
| 24 May 2026 |
Abaloparatide |
5.5 |
5mg |
6.2mg |
+24.8% |
98.88% |
Lab G |
| 24 May 2026 |
Trenbolone Acetate Raw |
4.0 |
5g |
4.6g |
-7.4% |
98.32% |
Lab C |
| 24 May 2026 |
SNAP-8 |
7.2 |
30mg |
29.1mg |
-3.1% |
96.03% |
Lab B |
| 23 May 2026 |
5-amino-1MQ Oral |
7.5 |
50mg |
59.1mg |
+18.2% |
98.41% |
Lab D |
| 23 May 2026 |
MOTS-C |
4.8 |
20mg |
21.4mg |
+6.8% |
98.09% |
Lab C |
| 23 May 2026 |
Adipotide |
5.9 |
15mg |
16.1mg |
+7.6% |
97.11% |
Lab E |
| 23 May 2026 |
PE 22-28 |
4.8 |
10mg |
8.9mg |
-10.9% |
97.79% |
Lab B |
| 21 May 2026 |
IGF-1 LR3 |
5.3 |
15mg |
16.9mg |
+12.5% |
98.20% |
Lab D |
| 19 May 2026 |
AA Water |
4.0 |
50mg |
45.8mg |
-8.4% |
97.58% |
Lab D |
| 19 May 2026 |
Tesofensine |
6.7 |
100mg |
90.3mg |
-9.7% |
98.72% |
Lab C |
| 17 May 2026 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
6.0 |
50mg |
44.3mg |
-11.4% |
99.90% |
Lab G |
| 29 Jan 2026 |
Estradiol Cypionate |
5.9 |
100mg/ml |
116.3mg/ml |
+16.3% |
98.51% |
Lab B |
| 29 Jan 2026 |
MK-677 (Ibutamoren) Raw |
4.0 |
5g |
5.0g |
-0.1% |
95.20% |
Lab D |
| 29 Jan 2026 |
Vilon |
9.0 |
10mg |
10.2mg |
+2.2% |
97.70% |
Lab D |
| 26 Jan 2026 |
Abaloparatide |
9.3 |
10mg |
10.7mg |
+7.1% |
98.48% |
Lab D |
| 26 Jan 2026 |
GW-501516 (Cardarine) |
5.8 |
100mg |
122.1mg |
+22.1% |
95.64% |
Lab D |
| 26 Jan 2026 |
Lipo-C FOCUS 425mg |
9.7 |
250mg/ml |
268.2mg/ml |
+7.3% |
96.06% |
Lab F |
| 26 Jan 2026 |
PMK methyl glycidate CAS 1369021-80-6 |
7.6 |
500g |
448.3g |
-10.3% |
96.28% |
Lab D |
| 19 Jan 2026 |
KissPeptin-10 |
4.6 |
15mg |
15.3mg |
+1.7% |
95.89% |
Lab A |
| 19 Jan 2026 |
MOTS-C |
6.4 |
15mg |
14.7mg |
-1.8% |
97.30% |
Lab G |
| 19 Jan 2026 |
Winstrol Water (Stanozolol) |
9.9 |
200mg/ml |
189.8mg/ml |
-5.1% |
99.34% |
Lab D |
| 9 Jan 2026 |
CJC-1295 With DAC |
6.2 |
5mg |
4.6mg |
-8.5% |
95.53% |
Lab G |
| 9 Jan 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
7.9 |
5mg |
5.6mg |
+12.5% |
97.45% |
Lab E |
| 9 Jan 2026 |
Trestolone Acetate (MENT) Raw |
4.7 |
5g |
4.4g |
-11.4% |
96.36% |
Lab D |
| 7 Jan 2026 |
Trestolone Acetate (MENT) Raw |
4.0 |
10g |
9.2g |
-8.5% |
97.31% |
Lab D |
| 6 Jan 2026 |
NA Semax Amidate |
6.5 |
30mg |
25.6mg |
-14.6% |
99.97% |
Lab A |
| 6 Jan 2026 |
Semax |
4.2 |
2mg |
2.0mg |
-2.5% |
95.93% |
Lab E |
| 12 Dec 2025 |
4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 |
10.0 |
5g |
5.3g |
+5.8% |
99.38% |
Lab D |
| 12 Dec 2025 |
Anavar (Oxandrolone) |
5.8 |
100mg |
91.7mg |
-8.3% |
98.79% |
Lab F |
| 5 Dec 2025 |
ACE-031 |
5.2 |
50mg |
50.5mg |
+1.1% |
95.72% |
Lab C |
| 23 Nov 2025 |
17a-Methyl-1-Testosterone |
4.6 |
100mg |
117.8mg |
+17.8% |
98.04% |
Lab C |
| 23 Nov 2025 |
ACE-031 |
5.6 |
30mg |
26.8mg |
-10.8% |
99.65% |
Lab A |
| 23 Nov 2025 |
HMG |
7.7 |
50mg |
52.1mg |
+4.1% |
99.83% |
Lab A |
| 17 Nov 2025 |
NA Semax Amidate |
4.5 |
20mg |
19.6mg |
-1.8% |
99.48% |
Lab C |
| 17 Nov 2025 |
SNAP-8 |
4.0 |
20mg |
24.6mg |
+23.2% |
98.30% |
Lab B |
| 14 Nov 2025 |
BMK ethyl glycidate CAS 41232-97-7 |
7.2 |
10g |
12.4g |
+24.4% |
99.84% |
Lab B |
| 5 Nov 2025 |
HMG |
5.6 |
5mg |
6.0mg |
+20.0% |
95.24% |
Lab G |
| 5 Nov 2025 |
Hyaluronic acid |
5.5 |
20mg |
20.0mg |
+0.2% |
96.87% |
Lab G |
| 4 Nov 2025 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
4.3 |
20mg |
24.9mg |
+24.4% |
96.30% |
Lab G |
| 17 Oct 2025 |
Hyaluronic acid |
5.0 |
10mg |
10.2mg |
+2.4% |
99.12% |
Lab D |
| 9 Oct 2025 |
Adipotide |
6.2 |
2mg |
2.3mg |
+13.1% |
99.77% |
Lab A |
| 2 Apr 2025 |
Tirzepatide |
|
8.0 |
30mg |
(no batch claim) |
29.04mg |
(no batch ID) |
| 2 Apr 2025 |
Tirzepatide |
|
5.8 |
15mg |
(no batch claim) |
15.5mg |
(no batch ID) |
| 2 Apr 2025 |
Tirzepatide |
|
6.8 |
15mg |
(no batch claim) |
13.69mg |
(no batch ID) |
| 28 Mar 2025 |
Retatrutide |
|
3.9 |
20mg |
(no batch claim) |
22.28mg |
(no batch ID) |
| 21 Feb 2025 |
CJC-1295 |
No DAC |
5.0 |
5mg |
5.5mgpackage |
6.17mg |
22470 |